Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Enza Scarlato
Observed name:
E. Scarlato
Institution:
University of Verona
Observed institution:
University of Verona
ORCID:
0009-0009-3263-9830
Observed ORCID:
0009-0009-3263-9830
OpenAlex ID:
A5034504444
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2023
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
·
Cancer Research
·
37
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
2024
·
Silvia Pietrobono
, Monica Bertolini
, et al.
·
npj Precision Oncology
·
16
Targeted therapeutic strategies in rare subtypes of pancreatic cancer: Histology, molecular profiles, and emerging opportunities
2026
·
Enza Scarlato
, Nelson Dusetti
, et al.
·
Cancer Treatment Reviews
·
2
EGFR ligand Angiogenin predicts response to ALK5 inhibition in pancreatic cancer via a TNF-α paracrine axis in tumor-associated macrophages
2026
·
Silvia Pietrobono
, Veronica De Vita
, et al.
·
Oncogene
·
1
PDF
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns
2026
·
Simona Casalino
, Enza Scarlato
, et al.
·
European Journal of Cancer
Author Correction: CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
2026
·
Silvia Pietrobono
, Monica Bertolini
, et al.
·
npj Precision Oncology
PDF
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: updated analysis of survival and circulating and genetic biomarkers from the phase II nITRO trial
2026
·
E. Scarlato
, V. Merz
, et al.
·
ESMO Open
Early-onset enriches the identification of actionable alterations in patients with KRAS wild-type pancreatic ductal adenocarcinoma
2025
·
E. Scarlato
, S. Casalino
, et al.
·
ESMO Gastrointestinal Oncology
PDF
107P Early-onset enriches the identification of actionable alterations in patients with KRAS wild-type pancreatic ductal adenocarcinoma
2025
·
E. Scarlato
, S. Casalino
, et al.
·
ESMO Open
Abstract 2495: CCL3 predicts an exceptional response to TGFβ inhibition in pancreatic ductal adenocarcinoma by sustaining a basal-like ecotype enriched in LIF-producing macrophages
2024
·
Silvia Pietrobono
, Monica Bertolini
, et al.
·
Cancer Research
Supplementary Data from Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2024
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
Data from Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2024
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
Data from Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2024
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
Show more works
View as search
Works count:
13
Citation count:
56
H-index:
2
I10-index:
2
Year
Topic
Type